I thought how it would be helpful to point out that cannabis, in the form of a purified CBD oil called Epidiolex, has been approved as a medical treatment for certain types of epilepsy in children by the FDA in the U.S., the EMA in Europe, and NICE/MHRA in the U.K.
I assume those involved in the cannabis industry are aware that there is a well-defined medical pathway within the Cannabis Act that provides a mechanism by which patients can undergo a consultation with a physician or nurse practitioner and be provided medical direction, oversight, follow-up and medical authorization to receive cannabis.
Producing a consistent cannabis product form batch-to-batch is a challenge faced by licensed producers of cannabis, but that should not serve as rationale to delegitimize cannabis as a medicine.
In the end, the opinion piece does a great disservice to the many children and families struggling with epilepsy and I am grateful the vast majority of Canadians have moved beyond the type of thinking presented in this article.